Quantificare Alternatives & Competitors

4 companies similar to Quantificare

China Med Device

Your regulatory and business partner | Access China’s $80B Medtech market | MedDev/IVD | 1...

North Andover, United Sta...

Biotechnology Health Care +1

Bioserv Corporation

Your satisfaction is our number one goal. We know what needs to be done!

San Diego, United States

Biotechnology Life Sciences +3

Patheon

An integrated CDMO partner for every step in your drug development journey

2445

Waltham, United States

Biotechnology Manufacturing +1

CMAB Biopharma

Exclusively focused on delivering fully integrated CDMO services for biologics

38 Series B $72.00M

Suzhou, China

Biopharma Biotechnology +1

Frequently Asked Questions

Companies similar to Quantificare include China Med Device, Bioserv Corporation, Patheon, CMAB Biopharma. They work in Biotechnology and Manufacturing.

Bounce Watch lists 4 companies that share Quantificare's industries and are closest to it in business tags, services, target customers, business model and size.

QuantifiCare is a fast-growing Imaging CRO founded in 2001. Specializing in offering pre-clinical to phase IV clinical trial services across various clinical areas to pharmaceutical, biotech, and cosmetic industries. The company also provides innovative imaging tools tailored for medical specialists, including plastic...

Don't just read about them. Follow them.

BounceWatch watches Quantificare and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Quantificare Profile China Med Device Alternatives Bioserv Corporation Alternatives Patheon Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Quantificare on 14 Sep 2024. The 4 companies listed here were last checked between 12 Sep 2024 and 27 Oct 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.